Electronic cigarettes have been around for some time now, but the industry is still in its infancy. This hasn’t stopped it from growing to a 2.5$ billion income. Although many users see it as a fairly decent alternative to tobacco cigarettes, the FDA has yet to deem them safe. As a matter of fact, earlier this April, the Food and Drug Administration proposed the banning of e-cigarettes for … [Read more...]
FDA okays Northera capsules to Treat rare Blood Pressure ailment
The U.S. Food and Drug Administration has given green signal to Chelsea Therapeutics 's new drug Northera that helps in treating a rare low blood pressure disorder. Northera capsules (droxidopa) got approval from the federal agency early this week. The drug helps in treating a rare form of low blood pressure disorder called neurogenic orthostatic hypotension (NOH). Neurogenic orthostatic … [Read more...]
New Artificial Sugar Substitute Advantame Approved By FDA
An update was released by FDA containing the improvement of a new (artificial sweetener) food additive known as Advantame. The release was made on On May 19, 2014. Advantame (N-[N-(3-[3-hydroxy-4-methoxyphenyl) propyl]-L-?-aspartyl]-L-phenylalanine 1-methyl ester) developed and manufactured by Japanese manufacturer Ajinomoto, is a combination of aspartame ( NutraSweet) and vanillin (an … [Read more...]
Pap smears HPV Screening Test Approved by FDA
The Food and Drug Administration (FDA) has given its green signal to Roche Molecular Systems’s alternative papilloma virus test to treat cervical cancer, in women aged 25 and older. The test, commonly known as the Cobas HPV test, is a DNA-based test for the virus that can cause cervical cancer. Such DNA-based tools are being used by the doctors as a follow-up to confirm Pap test results. But … [Read more...]
Electric shock devices to be history soon as FDA mulls its permanent ban
The shock devices and treatments will be a history soon as the Food and Drugs Administration is mulling over permanently banning such electric-shock devices used as therapies to treat patients with developmental disabilities and mental problems. In its 126-page report this week, the federal body has declared that it is reviewing electrical stimulation devices and may permanently ban their use … [Read more...]
FDA gives nod to controversial Cobas HPV test
The Food and Drug Administration (FDA) has given its green signal to Roche Molecular Systems’s alternative papilloma virus test to treat cervical cancer. The test, commonly known as the Cobas HPV test, is a DNA-based test for the virus that can cause cervical cancer. The research and clinical trial for the newly FDA-approved Cobas HPV test was conducted in Pleasanton. After the FDA nod, the … [Read more...]
FDA gives green signal to Ragwitek to treat pollen allergies, hay fever
The Food and Drug Administration (FDA) has given its green signal to Ragwitek, an allergen extract, to treat short ragweed pollen induced allergic rhinitis or hay fever. The drug, administered under the tongue, helps in treating hay fever (with or without conjunctivitis) in those in age group 18 and 65. Ragwitek contains an extract from short ragweed (Ambrosia artemisiifolia) pollen. One … [Read more...]
FDA’s no to wider use of Johnson & Johnson’s Xarelto drug
In a major setback to drug maker Johnson & Johnson, the US Food and Drug Administration has rejected its drug application for a third time. The firm has sought permission from the agency to expand use of the blood thinner Xarelto to reduce dangerous blood clots and related problems in patients with coronary artery disease. But much to the disappointment for the company, the FDA rejected its … [Read more...]
GSK wins FDA approval for Mekinist-Tafinlar combination to treat melanoma
GlaxoSmithKline (GSK) has got green light from the Food and Drug Administration (FDA) for using a drug combination to treat melanoma, the deadliest form of skin cancer. The US regulator has approved GSK for the combined use of Tafinlar, also known as dabrafenib, and Mekinist, or trametinib for melanoma medication. The FDA approval was announced late on Wednesday. It is noteworthy that the … [Read more...]
